[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367229-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367229-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-dual-role-of-circhipk3-in-cancer-and-its-implications-for-multiple-drugs-resistance-a-systematic-review-and-computational-approach","The dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: a systematic review and computational approach","","circHIPK3 circular RNA in cancer is debated as an oncogene or a tumor suppressor, prompting a systematic effort to clarify its dual role across cancers. Available evidence on circHIPK3 interactions with sponged miRNAs and RNA-binding proteins was gathered, then complemented with computational analyses. Searches covered major biomedical databases up to October 2024 under PRISMA. Results highlight circHIPK3 regulation of multiple miRNAs and downstream pathways relevant to tumor development and chemoresistance, including MAPK, Jak/STAT3, Wnt/β-catenin and PI3K/Akt.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-dual-role-of-circhipk3-in-cancer-and-its-implications-for-multiple-drugs-resistance-a-systematic-review-and-computational-approach/367229/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-dual-role-of-circhipk3-in-cancer-and-its-implications-for-multiple-drugs-resistance-a-systematic-review-and-computational-approach/367229.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study on circHIPK3?","Question",{"text":63,"@type":64},"To understand the dual role of circHIPK3 in different cancers and to systematically gather evidence of its interactions with sponged miRNAs and RNA-binding proteins in oncological diseases.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which databases and guideline were used for the systematic review?",{"text":68,"@type":64},"PubMed, BioMedCentral, Web of Science, Embase, and Scopus were searched for studies published until October 2024, following the PRISMA guideline.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the results show about circHIPK3 interactions?",{"text":72,"@type":64},"circHIPK3 is reported to regulate 33 miRNAs affecting 399 target genes, with well-documented interactions involving miR-124-3p, miR-637, and miR-338-3p that may influence major cancer-related signaling pathways.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367229,1790217403,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Systematic Review PUBLISHED 21 February 2025 DOI 10.3389/fonc.2025.1547889  \nOPEN ACCESS  \nEDITED BY  \nTao Liu,  \nUniversity of New South Wales, Australia  \nREVIEWED BY  \nJiang Zhu,  \nShandong University, China Xiaochun Sun,  \nJiangsu University, China  \n*CORRESPONDENCE  \nAdenilson Leão Pereira  \n [adenilsonlp@ufpa.br](adenilsonlp@ufpa.br)  \n†These authors have contributed equally to this work  \nRECEIVED 18 December 2024  \nACCEPTED 31 January 2025  \nPUBLISHED 21 February 2025  \nCITATION  \nCampelo MM, Reis-das-Mercˆes L, Vidal AF, da Silva FRP, de Oliveira ACA, Monteiro JRdS, Cabral CG, Noronha RCR and Pereira AL (2025) The dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: a systematic review and computational approach.  \nFront. Oncol. 15:1547889 .  \ndoi: 10.3389/fonc.2025.1547889  \nCOPYRIGHT  \n© 2025 Campelo, Reis-das-Mercˆes, Vidal, da Silva, de Oliveira, Monteiro, Cabral, Noronha and Pereira. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: a systematic review and computational approach  \nMarcelo Monteiro Campelo 1†, La ´ıs Reis-das-Mercˆes 2†, Amanda Ferreira Vidal 3, Felipe Rodolfo Pereira da Silva 1,4, Ana Carolina Alves de Oliveira 1,  \nJos´e Rog´erio de Souza Monteiro 1, Caique Guimarães Cabral 1, Renata Coelho Rodrigues Noronha 5  \nand Adenilson Leão Pereira 1,4*  \n1 Laboratory of Genetics and Evidence-Based Medicine, Faculty of Medicine, Federal University of Par´a, Altamira, Par´a, Brazil, 2 Laboratory of Human and Medical Genetics, Institute of Biological Sciences, Graduate Program of Genetics and Molecular Biology, Federal University of Par´a, Bele´m, Par´a, Brazil, 3Vale Institute of Technology, Bele´m, Par´a, Brazil, 4Graduate Programin Biodiversity and Conservation, Federal University of Par´a, Altamira, Par´a, Brazil, 5 Laboratory of Genetics and Cell Biology, Centro de Estudos Avançados da Biodiversidade (CEABIO), Federal University of Par´a, Bele´m, Par´a, Brazil  \nBackground: circHIPK3 role in cancer as oncogene or tumor suppressor is still debated, therefore, this study aimed to understand the dual role of this circRNA indifferent cancers. Furthermore, all available evidence of circHIPK3 interactions with sponged-miRNA and RBPs in oncological diseases were systematically gathered to better understand the its functional role in cancer.  \nMethods: PubMed, BioMedCentral, Web of Science, Embase and Scopus databases were searched for articles published until October 2024, following the PRISMA guideline. In computational analysis, miRNAs’ sponged target genes and RBPs were used for gene enrichment in KEGG, REACTOME and Gene Ontology, and TISSUES expression. miRTargetLink 2 . 0 was used to search for target genes, and STRING v.12. 0 for gene enrichment.  \nResults: circHIPK3 can regulate 33 miRNAs which regulate 399 target genes, and that were mainly enriched in major biological pathways important for cancer development and promoting. circHIPK3/miR-124-3p/miR-637/miR-338-3p are the most well documented interactions in cancers that may control MAPK, Jak/ STAT3, Wnt/b-catenin, and PI3K/Akt signaling pathways. circHIPK3 regulates miRNAs that modulate genes responsible for chemoresistance, such as ATPbinding cassette and solute carrier transporters genes, and DNA repair genes. circHIPK3 has binding sites for RBPs, which participate mainly of RNA processing and control, and gene expression regulation. Finally, we believe that it has anonco-circRNA role in most cancers, except in bladder cancer, whe","cbCaivPb7aTF1m5y","https://ap.wps.com/l/cbCaivPb7aTF1m5y","pdf",2434957,17,"English","# Background\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is the main goal of the study on circHIPK3?\",\"answer\":\"To understand the dual role of circHIPK3 in different cancers and to systematically gather evidence of its interactions with sponged miRNAs and RNA-binding proteins in oncological diseases.\"},{\"question\":\"Which databases and guideline were used for the systematic review?\",\"answer\":\"PubMed, BioMedCentral, Web of Science, Embase, and Scopus were searched for studies published until October 2024, following the PRISMA guideline.\"},{\"question\":\"What do the results show about circHIPK3 interactions?\",\"answer\":\"circHIPK3 is reported to regulate 33 miRNAs affecting 399 target genes, with well-documented interactions involving miR-124-3p, miR-637, and miR-338-3p that may influence major cancer-related signaling pathways.\"}]","The dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: a systematic review and computational approach | PDF",1790169788,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd55a33b881410fc74857c2ce1f9cb17.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e96df12d4d071994221b2d99d5af4088.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90de727dffb3baf644bcb829d3f9e21b.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3757edce4514e086125bc7575116acc6.webp",980,1385]